Nightingale C H, Klimek J J, Quintiliani R
Antimicrob Agents Chemother. 1980 Apr;17(4):595-8. doi: 10.1128/AAC.17.4.595.
At various times before surgery, 33 patients undergoing coronary artery bypass or cardiac valve replacement surgery received a single 2.0-g dose of either cefazolin or cephradine. Simultaneous single serum, atrial appendage, and pericardial fluid samples were obtained from the patients at various times and analyzed for drug content. Compared with cephradine, cefazolin yielded higher total serum, atrial appendage, and pericardial fluid levels. Unbound (free) levels of cephradine in serum and pericardial fluid were, however, higher than those of cefazolin. It remains uncertain whether the higher and more prolonged total levels of cefazolin in the right atrial appendage and in serum, or the higher free levels of cephradine in pericardial fluid and in serum, provide either one with a therapeutic advantage.
在手术前的不同时间,33例接受冠状动脉搭桥术或心脏瓣膜置换术的患者接受了单次2.0克剂量的头孢唑林或头孢拉定。在不同时间从患者身上同时采集单次血清、心耳和心包液样本,并分析药物含量。与头孢拉定相比,头孢唑林在血清、心耳和心包液中的总水平更高。然而,血清和心包液中头孢拉定的游离水平高于头孢唑林。目前尚不确定头孢唑林在右心耳和血清中的总水平较高且持续时间较长,还是头孢拉定在心包液和血清中的游离水平较高,是否能为其中任何一种药物带来治疗优势。